Infarct in new territory after endovascular stroke treatment: A diffusion-weighted imaging study. by Kaesmacher, Johannes et al.
1Scientific RepoRtS |         (2020) 10:8366  | https://doi.org/10.1038/s41598-020-64495-2
www.nature.com/scientificreports
infarct in new territory after 
endovascular stroke treatment: A 
diffusion-weighted imaging study
Johannes Kaesmacher1,2,3,6, Christoph Kurmann1,6, Noel Jungi2, Philipe Breiding1, 
Matthias F. Lang1,3, Raphael Meier4, Tomas Dobrocky1, Eike Piechowiak1, Felix Zibold1, 
Sebastian Bellwald2, Thomas R. Meinel  2, Mirjam R. Heldner2, Pasquale Mordasini1, 
Marcel Arnold2, Pascal J. Mosimann1, Mayank Goyal5, Jan Gralla1,6 & Urs Fischer2,6 ✉
Data on infarcts in new territory (INT) in patients undergoing endovascular stroke treatment for 
acute large-vessel occlusions are sparse. Aim of this study was to assess the prevalence, risk factors, 
and clinical relevance of INT. For this purpose, all patients in a single-center prospective registry who 
underwent endovascular stroke treatment and received pre- and post-interventional diffusion-weighted 
imaging were included (N = 259). Using an established scoring system, INT were classified according 
to size (I-III, ≤2 mm, >2 mm ≤20 mm, >20 mm) and likelihood of being related to the intervention 
(A, high likelihood; B, low likelihood). Additionally, a new type of infarct, that occurred in a territory 
distal to the occlusion, but was initially not hypoperfused, was defined as an infarct in initially not 
hypoperfused territory (IINHT). A total of 180 INT and 38 IINHT were observed in 32.8% (N = 85/259) 
of patients. In most patients, INT were angiographically occult (90.2%), and 13 patients had INT/IINHT 
larger than 2 cm (type III). Absence of protection during stent-retrieval and a cardio-embolic stroke 
origin were associated with higher incidence of INT/IINHT, whereas pretreatment with IV tPA showed 
no association, even when different bolus timing was considered. INT/IINHT were associated with lower 
rates of functional independence with increasing size type after adjusting for confounders (adjusted 
Odds Ratio per size group increase 0.63, 95% confidence interval 0.46–0.86). In conclusion, INT and 
IINHT are not rare, are associated with poor outcome with increasing size, and they may serve as a 
surrogate endpoint for safety evaluation of new devices and endovascular techniques. Further research 
on associated factors is warranted.
Infarct in a new territory (INT), which was initially not affected, is a potentially severe complication of endovas-
cular stroke treatment (EVT), and is associated with poor outcome1–5. Embolic complications can be detected 
on procedural or post-procedural angiography images, and are referred to as emboli in a new territory (ENT)4,5. 
Alternatively, they are found by evaluating new ischemic lesions on follow-up imaging, and are referred to as 
INT2,3,5. The latter approach is more sensitive for detecting non-apparent emboli, since it is able to detect very 
small infarcts and infarcts occurring in territories that are not made visible by procedural angiography (e.g. con-
tralateral hemisphere emboli originating from the aortic arch).
In the ESCAPE trial, around 10% of patients were found to have INT, based on post-procedural MRI includ-
ing diffusion-weighted imaging (DWI). The majority of these INT were in a pattern incompatible with a guide 
catheter origin3. Preliminary evidence from this and one other study suggested that pretreatment with intrave-
nous thrombolysis (IVT) may offer protection from INT6. Other studies, however, failed to reproduce this associ-
ation when considering ENT4,5. A common challenge in defining INT is that multiple occlusions or small infarcts 
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unrelated to the initially occluded territory may be present even before the intervention starts, potentially accom-
panying the pathology of the index stroke (e.g. disintegration of an unstable large artery or cardiogenic clot)3,7. In 
order to define new infarcts that are likely associated with the procedure an effective detection of infarcts before 
and after the procedure is therefore essential.
The aim of this study was to describe the frequency, types and severity of INT according to recently proposed 
criteria2. These criteria were applied in a cohort of patients with acute ischemic stroke who underwent endo-
vascular treatment together with pre- and early post-interventional MRI including DWI. Secondary objectives 
included the evaluation of associated factors and the clinical relevance of INT and their subtypes.
Methods
Study cohort and follow-up. All patients with intended endovascular treatment between January 2012 and 
August 2017 were screened for this study. Patients were included if their pre-interventional diagnostic work-up 
consisted of an MRI with DWI sequences and if they had undergone a follow-up MRI within 80 h after the inter-
vention (median delay after the intervention: 24 h, interquartile range 20–27 h, 55.2% ≤ 24 h, 92.7% ≤ 48 h, 98.5% 
≤ 72 h). Clinical and baseline characteristics of patients were extracted from the prospective Bernese Stroke 
Registry, as described previously7. Ethical approval for this retrospective analysis was obtained from the local 
ethics committee (Kantonale Ethikkommission für die Forschung Bern, Bern, Switzerland, amendment access 
number: 231/2014) and data collection was performed in accordance with relevant guidelines and regulations. All 
patients gave their informed consent or consent was waived as per institutional and ethics committee regulations, 
depending on the time of inclusion in the registry. For the prospective Bernese Stroke Registry, clinical functional 
outcome (modified Rankin Scale, mRS) is assessed at day 90 during a routinely scheduled clinical follow-up or – 
if the patient is unable to attend – by a trained and mRS-certified study nurse applying a standardized telephone 
interview. Favorable outcome was defined as modified Rankin Scale (mRS) ≤2. Neurological worsening was 
defined as an increase in the NIHSS score of ≥4 points.
Classification of INT and image analysis. Classification of INT was performed according to the meth-
odology proposed by Goyal et al.2. For this purpose, pre-procedural non-invasive imaging, post-procedural 
angiography images, and follow-up scans were reviewed using standardized data presentation and worksheets 
(Supplementary Figure e1 and Supplementary Table e1). INT was defined as a ‘new’ DWI lesion (i.e. not delin-
eated on pre-procedural non-invasive imaging) outside the affected territory (every territory that is not located 
distal to the clot). Each INT was then classified according to its size (types I-III, ≤2 mm, >2 mm - ≤20 mm, 
>20 mm, respectively) and likelihood of being related to the procedure: A - catheter was manipulated past 
the ostium of the new territory or B - catheter was not manipulated past the ostium of the new territory, see 
Supplementary Table e2 for further details)2. Classification according to catheter manipulation depended on 
the placement of the guiding/balloon guide catheter and/or distal aspiration catheter. In the present study, size 
classification was based on axial B1000 images using the largest diameter of the lesion. An example of a size type 
III manipulation type B INT is shown in Fig. 1. The following amendments to the classification proposed by 
Goyal et al. were made: (1) Number of INT was recorded, and, for each INT, size and type was determined; (2) 
If DWI showed a new lesion within the affected territory, but outside the initially hypoperfused area, as deter-
mined from pre-procedural MR perfusion imaging, this was considered as an infarct in initially not hypoperfused 
Figure 1. Large infarct in new territory without catheter manipulation across the ostium (type IIIB). (A,B) 
preinterventional diffusion-weighted imaging/apparent diffusion coefficient revealed mild diffusion restriction 
within the striatocapsular region and insular cortex on the right-hand side. No diffusion restriction in the 
contralateral hemisphere is delineable. (C,D) postinterventional DWI/ADC revealed marked diffusion 
restriction in the right middle cerebral artery territory without substantial infarct growth; however, a new DWI/
ADC lesion is seen in the contralateral hemisphere in close proximity to the precentral sulcus, corresponding 
to a size type III (>20 mm), manipulation type B (the catheter was not manipulated past the ostium of the new 
territory) infarct in new territory.
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territory (IINHT, see schematic overview in Fig. 2 and example case in Supplementary Figure e2). Additionally, 
the occurrence of DWI lesions outside the occluded territory on admission imaging and the presence of multi-
ple occlusions and the respective distinct hypoperfused areas were recorded (Supplementary Figure e3)7. Pre- 
and post-interventional MRIs were acquired using a 1.5/3T scanner (Magnetom Avanto or Magnetom Verio, 
Siemens, Erlangen, Germany). The institutional MRI protocol consisted of fluid-attenuated inversion recovery, 
DWI, susceptibility-weighted imaging, contrast-enhanced cervical angiography, intracranial time-of-flight angi-
ography and a gradient-echo dynamic susceptibility contrast perfusion sequence. Initial stroke lesion size before 
treatment was assessed with the DWI based Alberta Stroke Program Early CT Score (DWI-ASPECTS)8.
All pre-interventional contrast-enhanced MR angiographs were evaluated for aortic arch elongation and 
branching patterns as described previously9–11. For this purpose, the branching pattern was classified into 3 types 
according to the vertical distance from the innominate artery to the apex of the aortic arch. Classification as type 
I, II or III was based on this distance as follows: <1 diameter of the CCA (Type I), 1–2 diameter of the CCA (Type 
II) or >2 diameter of the CCA (Type III)9,11. In addition, the aortic arch was classified according to supraaortic 
branching patterns. Separate origins for the innominate, left common carotid, and left subclavian arteries was 
defined as a normal branching pattern10. A bovine arch was defined as a common origin of the innominate artery 
and the left common carotid artery, whereas branching of the left common carotid artery originating separately 
from the innominate artery was classified differentely10. As an indicator of aortic arch atherosclerosis, any aortic 
arch branch stenosis>50% was recorded as proximal supraaortic branch stenosis. We did not assess aortic arch 
atherosclerosis and or calcification independently owing to the often poor quality of contrast-enhanced MR angi-
ography at the caudal end of the field of view, and the lack of precision regarding the extent of calcifications when 
using contrast-enhanced MRA.
Endovascular treatment. General institutional eligibility criteria for acute ischemic stroke patients receiv-
ing endovascular treatment can be found online: http://www.neurologie.insel.ch/fileadmin/neurologie/neurolo-
gie_users/Unser_Angebot/Dokumente/Stroke_Guidelines_2018_01.pdf. Of all included patients, 220 patients had 
stent-retriever thrombectomy, 28 were treated with intra-arterial urokinase only, one patient with manual throm-
bus fragmentation was treated using a microwire and in 11 patients endovascular thrombectomy was withheld 
after partial or complete thrombolysis was noted on the first diagnostic angiography runs. When the institutional 
criteria for endovascular therapy were fulfilled, digital subtraction angiography was performed via a transfemoral 
approach by using a biplane, high-resolution angiography system (Axiom Artis zee; Siemens, Erlangen, Germany). 
Pre-interventional 3-vessel angiography was routinely performed to assess cross-flow and collaterals. According 
to the institution’s standard operating protocols, pre-interventional diagnostic angiography has to be performed 
within 3 minutes; otherwise, it was discontinued, and endovascular stroke treatment was initiated. For this pur-
pose, a 5F JB3 cerebral catheter (Cook Medical, Bloomington, Indiana, USA) was used. In 63.5% (N = 165) of 
Figure 2. Schematic representation of infarcts in new territory (INT) and infarcts in initially not hypoperfused 
territory (IINHT). Illustration by Anja Giger (Inselspital Bern, Bern, Switzerland).
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patients, diagnostic angiography was performed according to the standard operating procedure protocol, while 
in 20% (N = 52) only the two common carotid arteries were injected, and in 13.1% (N = 34) only the affected 
territory was displayed. In the remaining cases (3.5%, N = 9), one vertebral artery and one common carotid 
artery was injected. Stent-retriever-based thrombectomy was usually performed in conjunction with an 8F or 9F 
balloon-guide catheter (Merci Balloon Guide Catheter, Concentric Medical, Mountain View, California, USA; 
FlowGate Balloon Guide Catheter, Stryker, Kalamazoo, Michigan, USA). The catheter was placed in the cervical 
ICA using a long exchange wire (Supra Core Guide Wire, Abbott, Chicago, Illinois, USA) after diagnostic angiog-
raphy (N = 105/220, 47.7%). If the vascular architecture of the patient was deemed unsuitable for balloon-guide 
catheter placement, a distal access catheter was used instead (3MAX/5MAX ACE, Penumbra, Alameda, California, 
USA; DAC Catheter, Stryker; AXS Catalyst, Stryker; Sofia, Microvention, Aliso Viejo, California, USA; N = 94/220, 
42.7%). In a few cases, the distal access catheter was used as a second-line treatment if the initial attempt at placing 
a balloon-guide catheter was unsuccessful or reperfusion could not be achieved with this setup (N = 5/220, 2.3%). 
In the remaining patients, a balloon-guide catheter was primarily used together with a distal aspiration cathe-
ter in the same setup (N = 5/220, 2.3%). Most patients were treated using a Solitaire stent-retriever (Medtronic, 
Minneapolis Minnesota, USA). Intra-arterial urokinase was administered after failed intracranial access or if 
patients presented with distal vessel occlusions only12. For urokinase administration, a 6F or 8F guiding catheter 
was used and selective intracranial access was established using a 0.021.inch Prowler Select Plus (Codman, Boston, 
Massachusetts, USA) or an Excelsior SL-10 (Stryker) microcatheter. The dose of Urokinase administered varied 
between 250000 and 1000000 IU. Good-quality post-procedural overview runs for the evaluation of emboli in 
initially not hypoperfused territories were available for 253/259 (97.7%) of patients.
Statistical analysis. Continuous and discrete numerical variables are shown as median and interquartile 
range. Comparisons between frequency counts were made using chi-square or Fisher´s exact test (2 × 2 con-
tingency tables). Binary logistic regressions with dichotomized clinical outcomes as dependent variable were 
adjusted for the prespecified confounders age, sex, admission NIHSS, IV tPA, reperfusion success, DWI-ASPECTS 
and site of occlusion. For sensitivity purposes, patients were additionally divided into 3 groups: (1) patients who 
did not receive IV tPA, (2) patients in whom the interval between administration of the IV tPA bolus and the 
intervention was ≥70 minutes (=i.e. presumed low IV tPA concentration/no therapeutic concentrations) and 
(3) patients in whom the interval between IV tPA bolus administration and the intervention was <70 minutes 
(=i.e. presumed therapeutic tPA concentration). A potential effect of the time interval between intervention and 
post-interventional MRI on the occurrence of INT/IINHT was evaluated by comparing these metrics across INT/
IINHT-positive and negative patients. Statistical analyses were performed using SPSS statistics.
Results
Study cohort. Two hundred fifty-nine patients met the inclusion criteria (median age on admission: 71 
years, IQR 57–79 years, 49.0% female). Patients underwent endovascular treatment for severe strokes (median 
NIHSS 11, IQR 6–16) and mostly for anterior circulation occlusions (84.9%, N = 220). In total, 45.2% (N = 117) 
of patients were pretreated with IV tPA, and 69 patients (59.0.%) received an IV tPA bolus ≤70 minutes before the 
intervention. Successful reperfusion, defined as modified Thrombolysis in Cerebral Infarction (TICI) 2b/3, was 
achieved in 208 patients (80.3%). The median delay from start of intervention to follow-up MRI was 23 h (IQR 
20–27 h).
Frequency and types of INT and IINHT. One-hundred-and-eighty INT were recorded in 76/259 (29.2%) 
patients. Of the 180 INT, 76 (42.2%) were categorized as type A and 104 (57.8%) as type B (Fig. 3). Relative distri-
bution of INT according to size class was 51.1% (N = 92) type I, 44.4% (N = 80) type II and 4.4% (N = 8) type III 
(Fig. 3). At least one size type III INT was seen in 3.1% of patients (8/259), while 13.5% of patients (35/259) had 
at least one type A INT.
IINHT occurred in 15/259 (5.8%) patients (total number of IINHTs: 38). By definition, all IINHT were cat-
egorized as type A. Relative frequencies of size type I, II and III were 50.0% (N = 19), 36.8% (N = 14) and 13.2% 
(N = 5), respectively (Fig. 4 and Supplementary Figure e4). At least one INT or IINHT was observed in 85/259 
patients (32.8%). Taking INT and IINHT together, the frequency of patients with at least one size type III, at 
least one size type II (but not III), and at least one size type I (but not II or III) was 4.6% (N = 12/259), 17.8% 
(N = 46/259), and 10.4% (N = 27/259), respectively. More than two-thirds of patients with angiographically visi-
ble emboli developed an INT or IINHT (72.7%, 8/11), while only a minority of all INT/IINHTs was angiograph-
ically detectable (9.8%, 8/82; see Supplementary Table e3 A). Only 2/12 size type III infarcts were detectable on 
post- or peri-procedural angiography runs (Supplementary Table e3 B). The interval between procedure initiation 
and follow-up imaging did not differ significantly between INT/IINHT-positive and negative patients (median 
23.4 h vs 23.6 h, p = 0.998).
Factors associated with INT/IINHT. The presence of multiple occlusions or multiple embolic infarcts on 
admission did not differ between patients with and without INT/IINHT (4.6% vs 5.9%, p = 0.763 and 12.6% vs 
14.1%, p = 0.845, respectively, Table 1). Rates of IV tPA pretreatment did not differ between the groups (43.7% 
vs 48.2%, p = 0.509) and there was a tendency toward more cardioembolic strokes in patients experiencing INT/
IINHTs, which reached significance in dichotomization only (p = 0.045). This association was more pronounced 
when evaluating INT, IINHT and those without INT/IINHT separately, showing higher rates of cardioem-
bolic strokes in patients with INT (53.9% in INT, vs 36.2% in controls without INT or IINHTs, vs 11.1% in 
IINHTs, P = 0.005, Supplementary Table e4). There was a slight trend towards more INT/IINHT if only a cervical 
non-balloon-guide catheter was used instead of a balloon-guide catheter and/or a distal access catheter. However, 
other aspects of the intervention, including the location and mode of pre-interventional diagnostic angiography, 
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did not differ between the groups. Aortic arch elongation and branching anatomy patterns did not differ between 
patients who developed INT/IINHT and those who did not.
Sensitivity analysis regarding IV tPA administration and its timing. The presence of INT/IINHT 
was not associated with IV tPA pretreatment status, even when different endpoints and subgroups where consid-
ered (i.e. INT only, IINHT only, at least one type A INT/IINHT, at least one size type III INT/IINHT, see Table 2). 
Notably, comparable Odds Ratios were found when considering only patients treated with stent-retriever 
thrombectomy (Table 2). The likelihood of developing INT/IINHT were also similar among patients not receiv-
ing IV tPA, patients receiving IV tPA with bolus start to procedure initiation ≥70 min (i.e. no therapeutic con-
centration can be anticipated), and patients undergoing endovascular treatment <70 minutes after IV tPA bolus 
administration (i.e. therapeutic concentrations can be anticipated, see Supplementary Table e5).
Clinical relevance. Follow-up results were available for 241/259 patients (93.1%). Patients with INT/IINHT 
had lower rates of functional independence at day 90 (mRS 0–2, 57.7% vs 71.8%, p = 0.040, Supplementary 
Figure 3. Distribution of infarcts in new territory (INT). Most INT occurred when there was no catheter 
manipulation across the infarcts territory ostium (manipulation type B), and were small (size type I). The most 
common type of INT was IB (35%). Large INT were rare (5%).
Figure 4. Distribution of IINHTs. Relative frequency of infarcts in initially not hypoperfused territory (IINHT) 
occurring in 15 patients (6 with concomitant INT). Around 1 in 10 IINHT resulted in a large infarct ≥2 cm 
(N = 5/38, 13%).
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All (N = 259)
No INT/IINHT 
(N = 174)
INT/IINHT 
(N = 85) P
Age (years) 71.0 (58.0–79.1) 69.3 (57.5–78.9) 72.0 (60.3–80.0) 0.200
Sex, female 49.0% (127) 48.9% (85) 49.4% (42) >0.999
Risk factors
- Hypertension 68% (176) 64.9% (113) 74.1% (63) 0.157
- Atrial fibrillation 40.2% (104) 37.9% (66) 44.7% (38) 0.345
- Diabetes 18.5% (48) 19.0% (33) 17.6% (15) 0.866
- Hyperlipidemia 54.3% (140) 53.4% (93) 56.0% (47) 0.790
Admission NIHSS 11 (6–16) 11 (6–16) 11 (6–17) 0.947
Multiple occlusions on admission 5% (13) 4.6% (8) 5.9% (5) 0.763
Embolic infarcts outside hypoperfused areas 13.1% (34) 12.6% (22) 14.1% (12) 0.845
Site of occlusion 0.680
Posterior circulation 15.1% (39) 13.2% (23) 18.8% (16)
iICA / Carotid-T 17.8% (46) 19.5% (34) 14.1% (12)
M1 proximal 22.8% (59) 22.4% (39) 23.5% (20)
M1 distal 22.8% (59) 23.6% (41) 21.2% (18)
M2 19.3% (50) 19.5% (34) 18.8% (16)
M3/M4/A1/A2 2.3% (6) 1.7% (3) 3.5% (3)
IV tPA 45.2% (117) 43.7% (76) 48.2% (41) 0.509
DWI ASPECTS 8 (7–9) 8 (7–9) 8 (7–10) 0.921
TOAST 0.142
Large artery atherosclerosis 12% (31) 14.4% (25) 7.1% (6)
Cardioembolism 40.5% (105) 36.2% (63) 49.4% (42)
Other determined cause 8.1% (21) 8.6% (15) 7.1% (6)
Unknown cause/multiple causes 39.4% (102) 40.8% (71) 36.5% (31)
Cardioembolism vs other 40.5% (105) 36.2% (63) 49.4% (42) 0.045*
Treatment group 0.188
Stent-retriever thrombectomy 84.6% (219) 87.4% (152) 78.8% (67)
Intra-arterial thrombolysis 10.8% (28) 8.0% (14) 16.5% (14)
Manual fragmentation 0.4% (1) 0.6% (1) 0% (0)
No intervention 4.2% (11) 4.0% (7) 4.7% (4)
Cervical/intracranial access 0.127
Distal aspiration 36.3% (94) 37.4% (65) 34.1% (29)
Balloon-guide catheter 40.5% (105) 42.5% (74) 36.5% (31)
Distal aspiration and balloon guiding catheter as initial setup 1.9% (5) 2.9% (5) 0% (0)
Distal aspiration and balloon guiding catheter as secondary setup 1.9% (5) 1.7% (3) 2.4% (2)
Only non-balloon-guide catheter 19.3% (50) 15.5% (27) 27.1% (23)
Aortic arch anatomy
Supraaortal branch stenosis 33.1% (85/257) 30.8% (53/172) 34.1% (29/85) 0.670
Aortic arch elongation 0.141
Type I 37.4% (96/257) 33.1% (57/172) 45.9% (39/85)
Type II 22.2% (57/257) 23.3% (40/172) 20.0% (17/85)
Type III 40.5% (104/257) 43.6% (75/172) 34.1% (29/85)
Aortic arch configuration 0.578
Normal 72.0% (185/257) 73.8% (127/172) 68.2% (58/85)
Bovine 23.7% (61/257) 21.5% (37/172) 28.2% (24/85)
SOCCA 3.5% (9/257) 3.5% (6/172) 3.5% (3/85)
Aberrant subclavian artery 0.8% (2/257) 1.2% (2/172) 0% (0/85)
Pre-interventional diagnostic angiography only on affected 
hemisphere 13.1% (34) 14.9% (26) 9.4% (8) 0.245
Number of maneuvers 1 (1–2) 1 (1–2) 1 (1–2) 0.328
Procedure duration (min) 50 (28–86) 47 (28–81) 63 (30–97) 0.158
Cervical stenting 9.7% (25) 11.5% (20) 6.0% (5) 0.184
Table 1. Comparison of patients with and without INT/IINHT. INT, infarcts in new territory; IINHT, infarcts 
in initially non-hypoperfused territory; iICA, intracranial ICA; ASPECTS, Alberta Stroke Program Early 
Computed Tomography Score; TOAST, Trial of Org 10172 in Acute Stroke Treatment; Bovine, common 
aortic origin of the left CCA and brachiocephalic trunc; SOCCA, separate origin of the left CCA from the 
brachiocephalic trunk.
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Figure e4) and higher prevalence of neurological worsening (16.7%, vs 7.7%, P = 0.049). This association per-
sisted when analyses were confined to patients with IINHT without INT vs. controls (mRS 0–2 25.0% vs 71.6%, 
P = 0.01 and neurological worsening 55.6% vs 7.7%, P < 0.001).
Compared to patients without INT/IINHT, INT/IINHT patients showed a consistent trend toward poorer 
outcome with respect to increasing size type (Fig. 5). Implemented as a step-wise categorical variable ranging 
from the control group (no INT/IINHT, category 0) to at least one size type III infarct (category 3), increasing 
INT size was associated with lower functional independence (mRS 0–2) after adjusting for age, sex, NIHSS on 
admission, IV tPA, reperfusion success, DWI-ASPECTS and site of occlusion (aOR 0.63, 95% CI 0.46–0.86). A 
step-wise increase in INT/IINHT size was associated with neurological worsening, using the same covariates as 
in the model above (aOR 1.89, 95% CI 1.26–2.86).
Discussion
The main findings of this observational study were: (1) INT/IINHTs are not rare. They occur in about one-third 
of patients undergoing endovascular stroke treatment and some patients have multiple INT in different territo-
ries. (2) Most INT measure <2 cm and mostly occur in territories where no guiding or microcatheter manipula-
tion was performed across the INT territory orifices (manipulation type B). (3) INT/IINHT are clinical relevant 
depending on their size. (4) Risk factors seem to include treatment without flow manipulative protection devices 
and a cardioembolic origin of the stroke. (5) Endovascular treatment without IV tPA does not seem to increase 
the risk of developing INT/IINHTs.
Prevalence. We found a higher frequency of INT/IINHTs than reported in previous studies3,13. MRI with 
DWI has shown a much higher sensitivity than CT for detecting acute ischemia and our results show that most 
INT/IINHTs are smaller than 2 cm, underlining the need to distinguish between CT- and DWI-defined INT rates. 
Ganesh et al. reported 14 INT in 308 patients, resulting in a prevalence of 4.5%. However, only 59 patients were 
evaluated using MRI with DWI, and here the detection rate was more than doubled (11.7%)3. Although this is still 
considerably lower than the INT/IINHT prevalence that we observed, there is considerable uncertainty due to the 
small sample size. Additionally, the following factors may have contributed to this discrepancy. First, more than 
80% of the patients included in our cohort received pre-interventional diagnostic angiography in territories unre-
lated to the affected territory, thus giving rise to emboli associated with diagnostic angiography. Second, patient 
selection criteria in the ESCAPE trial were strict whereas there is a high chance of including older people with 
more vascular comorbidities in our cohort, potentially complicating angiography and resulting in more emboli.
Importantly, most INT/IINHTs were angiographically occult, corroborating findings on distal embolization 
during endovascular stroke treatment14 and lending further support to INT as a potentially more sensitive tech-
nical safety endpoint than angiographically observed ENT.
Justification for the introduction of IINHT. In the analyses presented, we have introduced another type 
of new infarct, namely infarcts in initially not hypoperfused territory. Goyal et al. defined INT as infarcts in a 
previously unaffected territory, based on individual anatomy2. We agree that, for example, anterior cerebral artery 
emboli after treatment of an intracranial carotid-terminus occlusion are not emboli in a new territory, because 
they are located in close anatomic proximity and directly distal to the occlusion site. However, such emboli may 
be the reason for infarcts occurring in a territory where they would most likely not have occurred if no treatment 
had been performed (i.e. when this territory was not hypoperfused initially) and are thus different from emboli 
in the territory of initial hypoperfusion. Another problem is that the final TICI score will only take into account 
emboli or residual perfusion deficits in the territory of initial hypoperfusion (the so-called ‘target territory’). 
Therefore, infarcts or emboli in initially not hypoperfused territories that occur directly distal to the occlusion site 
will not be considered as INT (according to their strict definition), nor will they affect (i.e. reduce) the final TICI 
score. As a result, we introduced the term “infarct in an initially not hypoperfused territory” (IINHT), which we 
consider potentially harmful emboli, and a subcategory of new infarcts. Adding to their theoretical relevance, 
Cohort Outcome Crude Odds Ratio (IV tPA) Adjusted Odds Ratio
Complete Cohort INT/IINHT 1.20 (0.71–2.0) 1.383 (0.793–2.412)
Complete Cohort INT 1.13 (0.66–1.94) 1.324 (0.74–2.37)
Complete Cohort IINHT 1.89 (0.98–1.11) 2.23 (0.71–7.04)
Complete Cohort Type A INT/IINHT 0.976 (0.517–1.843) 1.09 (0.55–2.15)
Complete Cohort Size Type III INT/IINHT 1.744 (0.54–5.65) 2.135 (0.60.-7.51)
Stent-Retriever only INT/IINHT 1.31 (0.74–2.33) 1.42 (0.78–2.58)
Stent-Retriever only INT 1.24 (0.68–2.25) 1.40 (0.74–2.63)
Stent-Retriever only IINHT 1.94 (0.62–6.14) 1.98 (0.57–6.82)
Stent-Retriever only Type A INT/IINHT 0.92 (0.45–1.89) 0.99 (0.47–2.09)
Stent-Retriever only Size Type III INT/IINHT 1.43 (0.42–4.82) 1.59 (0.43–5.81)
Table 2. Crude and adjusted Odds Ratios of IV tPA for different INT/IINHT endpoints. Adjusted for age, sex, 
stroke etiology, treatment group and type of protection (right column). INT, infarcts in new territory; IINHT, 
infarcts in initially non-hypoperfused territory; IV tPA, thrombolysis with intravenous tissue-type plasminogen 
activator.
8Scientific RepoRtS |         (2020) 10:8366  | https://doi.org/10.1038/s41598-020-64495-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
IINHTs were associated with neurological worsening and lower levels of functional independence, even when 
patients with INT were excluded.
Timing. We defined INT/IINHT as new infarcts following careful comparison of pre- and post- interven-
tional imaging. As post-interventional imaging was not routinely performed immediately after the procedure, it is 
uncertain exactly when these new infarcts occurred. Besides the possibility of being related to the interventional 
procedure, new embolic events may arise from the primary source of the initial large vessel occlusion (e.g. unsta-
ble cardiogenic thrombus or ruptured carotid-plaque). Although we were unable to determine the direct cause for 
INT/IINHT within the current study design, there are several arguments for and against the two possible main 
mechanisms (Table 3).
Associated factors and the role of IV tPA. We observed a higher frequency of INT/IINHT in patients 
in whom no balloon-guide catheter or distal access catheter was used during the procedure, in line with previous 
reports15, and a higher frequency of INT in patients with a cardioembolic stroke origin. The association between 
INT and cardioembolic origin seems reasonable, as most INT were classified as non-procedure-related and thus 
potentially derived from a systemic source, while IINHT are by definition related to the procedure itself.
No association was observed between simple aortic arch elongation metrics, branching patterns, and likeli-
hood of INT/IINHT occurrence. Furthermore, we were unable to reproduce the findings by Ganesh et al. and 
Goyal et al., who reported a reduced risk of INT in patients receiving IV tPA before endovascular treatment3,6. 
We performed several sensitivity analyses regarding the timing of IV tPA and different INT/IINHT definitions, 
but we were unable to detect an association. We cannot be sure, that our cohort was adequately powered to 
detect a potential treatment effect of IV tPA and confinement to patients with early follow-up MRI may have led 
to selection bias. In the future, randomized controlled trials including SWIFT-DIRECT, MR CLEAN-NO IV, 
SKIP, and the DIRECT MT trial may conduct secondary analyses to provide definitive evidence as to whether 
pre-interventional IV tPA can offer additional benefits regarding the occurrence of INT.
Strength and limitations. This study provides insight into the prevalence of new DWI lesions in patients 
undergoing endovascular treatment for large vessel occlusion strokes. A particular strength is the high diagnostic 
sensitivity of DWI for detecting ischemic lesions while ensuring high specificity by using a comparison to the 
pre-interventional lesion load. A possible limitation is that confinement to post-procedural MRI may carry the 
risk of selection bias, as patients who had worse outcomes (unstable, severe moving artifacts) may have been 
more likely to have a follow-up CT rather than MRI. Hence, there is a risk that the incidence of severe, clinically 
apparent INT (e.g. large ACA infarcts) was underestimated. In addition, some patients were examined using e.g. 
1.5T post-interventionally and 3T pre-interventionally or vice versa, potentially leading to some uncertainty 
Figure 5. Outcome of patients with strata of INT/IINHT and their size. (A) Increased INT/IINHT size was 
associated with worse outcome; for classification purposes patients with multiple INT/IINHT received the 
class according to their largest size. (B) Odds Ratios for mRS 0–2 (comparator: no INT/IINHT) derived from 
binary logistic regression with functional independence as dependent variable (cf. methods for covariates in the 
model). P for trend was evaluated using an extended Mantel Haenszel chi-square for linear trend (one degree of 
freedom) including a continuity correction. The adjusted Odds Ratio per size increment was aOR 0.63, 95% CI 
0.46–0.86.
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regarding the sensitivity of DWI according to magnetic field strength16. Furthermore, the generalizability of our 
results is limited as not all institutions perform diagnostic angiography before an intervention, which may affect 
the occurrence of INT. Moreover, some of the patients included were treated with older treatment modalities 
only. Finally, aspiration-only techniques were not used, and their application might have affected the occurrence 
of INT/IINHTs.
conclusion
INT and IINHT are not rare, often angiographically occult, and may serve as a surrogate endpoint for safety eval-
uation of new devices and endovascular techniques in the future. Neurological worsening and functional deficits 
associated with INT and IINHT increase in severity according to their size, and further research on factors asso-
ciated with such infarcts is warranted.
Data availability
Raw data on this cohort can be made available upon request to the corresponding author and after clearance by 
the local ethics committee.
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Arguments in favor of being related to the procedure Arguments against being related to the procedure
If the index event is caused by an unstable thrombus or plaque, which causes 
subsequent infarction to other territories, patients with several emboli or 
multiple occlusions on admission should be more likely to develop INT/IINHT.
Ganesh et al. found a comparable frequency of INT in 
patients treated with IV tPA alone and those additionally 
treated with mechanical thrombectomy3.
If INT are unrelated to the procedure, they can be expected to occur randomly 
in intracranial territories. However, the percental occurrence of type A 
manipulation types was close to 50%, thus clearly over-representing territories 
with a close proximity to the occlusion site and where catheter manipulation 
took place.
INT also occurred in patients receiving only diagnostic 
angiography and thus not all infarcts can be associated 
with the interventional part of angiography (although 
occurrence due to diagnostic angiography is possible).
Theoretically, a prolonged time interval between the endovascular procedure 
and follow-up MRI should extend the period during which INT unrelated to the 
procedure could occur. However, no such association was noted.
Table 3. Considerations regarding the potential cause of INT/IINHT.
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